European Pharmaceutical Review

OCTOBER 10, 2024

This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). The final strategy is anticipated to be adopted by March 2025, according to EMA and HMA. Feedback on the draft strategy can be submitted online here until 30 November 2024.

Medicine 98

Medicine Networking Competition Pharmaceutical 98

Clarify Health

NOVEMBER 15, 2021

Medicare Advantage is expected to reach 40% penetration by 2025. For health plans looking to grow their share of this market, they need to ensure that they’re as competitive as possible. For one national health plan, the strategy to improve and expand their Medicare Advantage networks was built upon meeting competitive overlap targets.

Networking 52

Networking Competition Insurance Marketing 52

Clarify Health

NOVEMBER 15, 2021

Medicare Advantage is expected to reach 40% penetration by 2025. By 2023, available annual profit pools will range from $11 billion to $13 ­billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers¹.

Networking 52

Networking Competition Insurance Marketing 52

European Pharmaceutical Review

OCTOBER 31, 2024

Commitment to manufacturing the £520 million life sciences innovative manufacturing fund is very welcome, and will be crucial in helping to capture high-productivity investment” The Association of the British Pharmaceutical Industry (ABPI) backed the proposed measures to enhance life sciences competitiveness in the UK.

Manufacturing 52

Manufacturing Medical science Medicine Engineering 52

European Pharmaceutical Review

NOVEMBER 2, 2023

Sustainable biosimilar competition in Europe: can it be achieved? Stelara biosimilars in the US market The first Stelara biosimilars are expected to enter the US market in 2025. “We He added that the approval of Wezlana “could have a meaningful impact for patients managing their disease.”

Food and Drug Administration 98

Food and Drug Administration FDA Side effects Safety 98

Clarivate

AUGUST 7, 2024

These moves mark a strategic shift towards greater transparency and predictability, driven by regulatory pressures and rising competition from market disruptors. CVS Caremark CostVantage (to be launched in 2025) Cost-plus model, specifically for CVS’s retail pharmacies.

Retail 59

Retail Marketing Competition Biopharma 59

Pharmaceutical Technology

JUNE 7, 2023

Mounjaro’s approval for obesity, particularly in the US and EU markets, means the drug is entering a significantly large market where it will have direct competition from Novo Nordisk’s Wegovy (semaglutide), which is currently the leading glucagon-like peptide-1 (GLP-1) therapy approved for obesity by both the FDA and EMA.

Leads 98

Leads Marketing FDA Sales 98

PM360

SEPTEMBER 21, 2023

They do not have biosimilar or generic competition available in the market. Additionally, highly competitive classes, such as rapid-acting insulin and immunologics are included on the selected drug list. They do not qualify for any exemption (e.g., for orphan products or plasma therapies).

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Scott’s Directories

FEBRUARY 24, 2022

There are a few ways to help boost these sales and remain competitive. billion by the end of 2025, from $196.3 Having a competitive edge is essential in the growing healthcare market. When dealing with medical sales, utilizing a Canadian Doctors Directory is a sure way to generate new clients. billion in 2017”.

Medical sales 52

Medical sales Medical Sales Doctors 52

Pharmaceutical Technology

OCTOBER 31, 2022

Two categories of novel therapies stand out: cell therapies and therapies with novel MOAs, with new products in each category being forecast to launch between 2023 and 2025. However, the late-stage pipeline is seeing new companies enter the space, with intense competition for patient share driving innovation.

Marketing 59

Marketing Sales Patients Competition 59

Pharmaceutical Technology

NOVEMBER 22, 2022

China will continue to take steps towards becoming as competitive in high-value innovative pharma as it is in the generics industry, with The Wall Street Journal reporting Chinese biotechs raised $1.6tn through 568 venture financings last year, up from $11bn in 418 deals in 2020.

Manufacturing 64

Manufacturing Pharma Government FDA 64

Pharmaceutical Technology

FEBRUARY 23, 2023

Pivotal data is expected around May next year with the maintenance trial expected to read out in June 2025. The moderate to severe UC market is widely targeted by companies entering the space due to the large treatment population, but that also means there is fierce competition.

Marketing 59

Marketing Safety Competition Pharmaceutical 59

Clarivate

DECEMBER 7, 2021

The previously clear lines between sectors are blurring and the competitive set is widening. Indeed, millennial consumers are expected to drive 50% of luxury goods purchases by 2025. [1]. 1] The Drum, “Millennials and Gen Z to make up 50% of luxury spending by 2025” , January 2021. [2]

Professional Services 95

Professional Services Management Competition Sales 95

Pharmaceutical Technology

JANUARY 30, 2023

Figure 1 shows that of the 22 prophylactic vaccines, there was a significant decline between the H1 and H2 2022 forecasts, with the greatest decrease expected to occur in 2025. Likewise, Moderna’s Spikevax, the second leading COVID-19 vaccine with 19.5

Sales 52

Sales Leads Competition Medicine 52

Clarivate

AUGUST 27, 2024

FDA approval in the fourth quarter, with Johnson & Johnson’s Varipulse system close behind, so competition will pick up. Still, analysts and providers project that Farapulse, which has more than 70% of the global market today, will continue to dominate at least through 2025. Abbott’s Volt should join the party in early 2026.

Marketing 52

Marketing Competition FDA Electronics 52

Pharmaceutical Technology

JULY 21, 2022

Pharma giant AstraZeneca also plans to make its supply chain carbon-negative by 2030; to reduce its Scope 1 emissions by 20%, Scope 2 emissions by 95%, and Scope 3 emissions by 25% per $1m of sales by 2025. Access to medication. According to the World Health Organization (WHO), two billion people lack access to essential or basic drugs.

Government 52

Government Healthcare Healthcare Pharma 52

Healthcare Success

SEPTEMBER 12, 2024

In this two-part series, I explore the evolution of organic and paid search, discuss its impact on your SEO strategy, and share how your healthcare organization can navigate these changes to enhance online visibility and remain competitive. First, let’s review the evolution of search and its impact on SEO. What’s Next for Search?

Engineering 62

Engineering Insurance Competition Leads 62

pharmaphorum

JULY 15, 2022

At the time, she said, “companies have to respect our competition rules and procedures. If it proves effective in the trial, the UK has said it could roll testing out to one million people in 2024 and 2025.

Competition 52

Competition Marketing Medicine Sales 52

Pharma Marketing Network

DECEMBER 17, 2021

Its sustainability platform, fueled by its Health for Humanity 2025 Goals, contributes to the global effort to achieve a majority of the SDGs by supporting 11 of the 17, spanning the spheres of global health, social justice, environmental stewardship, and responsible business practices. Health for Humanity 2025 Goals. The CSR Journal.

Pharma 103

Pharma Ethics Recruitment Government 103

Contrarian Sales Techniques

FEBRUARY 1, 2023

This is what sets your product apart from the competition and gives your customers a reason to choose your product over others. In addition, the global dairy market is projected to grow at a CAGR of around 4% from 2020 to 2025, driven by rising consumer demand for dairy products due to their nutritional value and health benefits.

Sales Strategy 52

Sales Strategy Sales Sales pitches Prospecting 52

PM360

JULY 13, 2023

billion by 2025, growing at a compound annual growth rate of 6.7%. Market research and competitive analysis Conduct thorough market research to understand the existing solutions and identify your competition. The global healthcare IT market was valued at $280.3 billion in 2020 and is expected to reach $381.7

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Clarivate

DECEMBER 7, 2023

Research and development (R&D) plays a fundamental role in generating the innovation that is essential for maintaining competitive advantage. We are pleased that Clarivate is included in the recently released Gartner report, Market Guide for Intellectual Property Management Software With R&D-specific Use Cases.

Management 59

Management Marketing Consulting Engineering 59

pharmaphorum

SEPTEMBER 11, 2022

Analysts at Mizuho have suggested that competition from BMS’ drug could trim Otezla’s 2025 sales from $3 billion to $2 billion, although Amgen is attempting to defend its product by expanded the label of the drug to include mild psoriasis. Otezla was acquired by Amgen for $13.4

FDA 52

FDA Marketing Sales Patients 52

Clarify Health

DECEMBER 5, 2023

CMS will require compliance with these last few elements starting January 1, 2025. On the other hand, providers can use pricing information to position themselves competitively in the market. For providers, knowing the market rates for various services helps in setting competitive yet profitable prices.

Healthcare 52

Healthcare Healthcare Competition Marketing 52

Clarivate

JANUARY 23, 2024

R&D spend is steadily growing and is expected to reach approximately $200 billion by 2025. Spend is growing, but ROI is TBD However, when looking at the potential commercial value of this R&D activity, some challenges remain. This amounts to approximately 20% of sales revenues which are reinvested into developing pipelines.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Rep-Lite

JULY 27, 2023

billion by 2025. Moreover, we’ll shed light on the evolution of medical sales techniques and strategies, the impact of technology, and the importance of talent acquisition to thrive in this competitive domain. Attracting and Retaining Top Sales Talent A competitive compensation package is just the beginning.

Sales 52

Sales Medical Medical sales Sales Strategy 52

Integrity Solutions

JULY 31, 2024

Today, amid market volatility, changing customer expectations and heightened competition, it’s more important than ever. Especially in a tight job market, talented salespeople are one of your biggest competitive differentiators. All told, an irresistible sales culture can become your biggest competitive advantage.

Sales 66

Sales Management Training Product Knowledge 66

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting. The situation was reversed only 25 years ago.

Pharmaceutical 95

Pharmaceutical Manufacturing Medicine Competition 95

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. If you have to wait to extract meaning from your data then you won’t be competitive enough. “A

Marketing 98

Marketing Pharma Healthcare Healthcare 98

Med Device Careers

JANUARY 3, 2022

and the global IC device market is projected to reach over $20 billion dollars by 2025. The career opportunities are highly desirable, competitive, and rewarding with starting U.S. Regarding the job market and potential for career growth, healthcare makes up over 11 percent of the workforce in the U.S.

Specialization 52

Specialization Medical Engineering Healthcare 52

European Pharmaceutical Review

AUGUST 23, 2022

The regulation will be applied by 12 January 2025 and will therefore take three years to become effective in Member States (and thus to fully appreciate its impact). Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU.

Consulting 98

Consulting Medical Healthcare Healthcare 98

Medico Reach

AUGUST 30, 2022

By 2025, the campaign hopes to impact the community of three billion people annually. The Anne Arundel’s Medical Center hosted a competition that required participants to submit a selfie with a natural or fake mustache. The competition blended humor with the concerning health issues that men face during their lifetime.

Healthcare 52

Healthcare Healthcare Marketing Medical 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

In 2021, the WHO and the United Nations announced a plan to reduce premature mortality related to noncommunicable diseases, including cardiovascular disease, by 25% leading up to 2025. The company now faces a highly competitive generics market for its lead drug. GlobalData is the parent company of Pharmaceutical Technology.

Pharmaceutical 52

Pharmaceutical Marketing FDA Leads 52

Quantified

SEPTEMBER 21, 2023

According to Gartner, 75% of B2B sales organizations will augment traditional playbooks with AI by 2025 despite the current low adoption rate. Competitive pressure will drive companies to invest in AI tools for sales. Making a prospect wait hours for a response will become a competitive disadvantage.

Sales 52

Sales Prospecting Training Sales tools 52

Clarify Health

NOVEMBER 27, 2019

This application applies to the 2021-2025 performance period. Competition is more center-stage than in previous models, including both voluntary beneficiary alignment and extra incentives for high performers. Beneficiary alignment, benchmarking methodology, and payment mechanisms differ for each type of entity.

Government 52

Government Competition Patients 52

Healthcare Success

NOVEMBER 7, 2022

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. As you likely already know, Medicare Advantage is growing, and the landscape is becoming more competitive. As a result, many U.S.

Marketing 52

Marketing Media Healthcare Healthcare 52

Clarify Health

DECEMBER 2, 2019

Performance years for Direct Contracting are 2021 – 2025. Introduces competition by: Incentivizing providers to attract and compete for the loyalty of beneficiaries, particularly new beneficiaries. This model evolves elements of legacy shared-savings programs and inherits some best-practices from industry payers.

Distribution 52

Distribution Marketing Competition Patients 52